The Astra Clinic has strong expertise and well-trained research staff for conducting Phase II, III, and IV pharmaceutical and medical device ophthalmology trials. Our goal is to deliver patient-centered care and stay at the forefront of scientific research.
The Clinical Trials Center was established in 2025 as a non-state healthcare facility. Our center specializes in conducting clinical trials of medicinal products. Since its establishment, we have been continuously striving to improve and professionalize the environment in which clinical trials are conducted. We follow the global trend of making clinical trials accessible to the general public.
At the center, we cooperate with a large number of regional physicians, specialists, and healthcare facilities, serving as their partner in facilitating access to clinical trials for their patients. Our main goal is to offer the public an additional option for addressing their health conditions and to provide our patients with high-quality healthcare in a pleasant and professional environment.
The following clinical trials are currently underway:
MK-8748-003 TORRONTES
Indication: Wet Form of Age Related Macular Degeneration
A randomized, double-masked, multicenter, 3-arm, pivotal phase 2/3 study to evaluate the efficacy and safety of IVT EYE201/MK-8748 compared to aflibercept 2mg in participants with NVAMD
MK-8748-004/005 / SANGIOVESE
Indication: Diabetic Macular Edema
A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema
Get in touch with us:
Phone/WhatsApp: +420 733 280 115
E-mail: info@astraclinic.cz
Address:
Chlumčanského 497/5, 180 00 Praha 8-Libeň, Czech Republic